Susannah Barbee, Ph.D.

Susannah Barbee, Ph.D., is Vice President, Translational Immunology, Deerfield Discovery and Development, and joined the Firm in 2024. Prior to Deerfield, Dr. Barbee spent four years with TRex Bio, most recently as a Vice President, Head of Translational Biology. Before TRex, she was with Five Prime Therapeutics for four years, most recently as Director, Immuno-Oncology Research and with Amplimmune for over five years most recently as an Associate Director, Research. Dr. Barbee holds an A.B. in Biochemistry and Molecular Biology from Harvard University and a Ph.D. in Biology from the California Institute of Technology.